Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MIG | 106.0 | 74 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MIG | 24.0 | 69 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MIG | 35.0 | 61 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MIG | 23.5 | 64 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MIG | 96.0 | 73 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIG | 33.0 | 61 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | MIG | 33.0 | 56 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIG | 233.0 | 55 | |
N2759 | TNF-a | 100 | ng/mL | 3 | MIG | 237.0 | 53 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIG | 48.0 | 48 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | MIG | 53.0 | 48 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIG | 137.5 | 66 | |
N2586 | TNF-a | 100 | ng/mL | 3 | MIG | 158.0 | 50 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIG | 17.0 | 67 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | MIG | 16.0 | 81 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIG | 51.0 | 67 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | MIG | 50.0 | 71 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIG | 16.0 | 55 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | MIG | 16.5 | 66 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIG | 24.0 | 63 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | MIG | 21.0 | 63 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | MIG | 14.0 | 62 | ||||
RA1869 | 3 | MIG | 11.0 | 63 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | MIG | 41.0 | 62 | ||||
N2759 | 3 | MIG | 47.5 | 48 |